EGFR and non-small cell lung carcinoma: He et al. [33] proposed that non-small cell lung cancer (NSCLC) patients with a family history of cancer, especially a family history of lung cancer, might have a significantly higher incidence of epidermal growth factor receptor (EGFR) activating mutation.